BDX - Becton, Dickinson and Company So'nggi... | Finranks

12.08.2026

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery FRANKLIN LAKES, N.J., Aug. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with successful completion of enrollment in the PREVENT clinical trial evaluating Phasix™ Mesh for the prevention of incisional hernias.

10.08.2026

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed.

08.08.2026

Becton, Dickinson and Company Q3 Earnings Call Highlights

Becton, Dickinson and Company NYSE: BDX reported third-quarter fiscal 2026 revenue of $5 billion, up 4.4% on an FX-neutral basis, as growth across its key platforms and operational productivity helped results exceed the company's expectations.

06.08.2026

BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down

BDX tops third-quarter fiscal 2026 earnings and revenue estimates as broad segment growth offset pressure on gross and operating margins.

06.08.2026

Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript

06.08.2026

Becton Dickinson Signals Strong Growth Momentum By Raising Profit Outlook

Becton, Dickinson and Co (NYSE:BDX) on Thursday reported third-quarter adjusted earnings of $3.23 per share, beating the consensus of $3.14.

06.08.2026

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
BDX	UBS	Buy	undefined >> $19	July 28th 2026

Press-relizlar

12.08.2026

Becton, Dickinson and Company (BDX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Becton, Dickinson and Company (BDX)

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Becton, Dickinson and Company Q3 Earnings Call Highlights

BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down

Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript

Becton Dickinson Signals Strong Growth Momentum By Raising Profit Outlook

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

BD Reports Third Quarter Fiscal 2026 Financial Results

Search stocks

Becton, Dickinson and Company (BDX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Becton, Dickinson and Company (BDX)

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Becton, Dickinson and Company Q3 Earnings Call Highlights

BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down

Becton, Dickinson and Company (BDX) Q3 2026 Earnings Call Transcript

Becton Dickinson Signals Strong Growth Momentum By Raising Profit Outlook

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

BD Reports Third Quarter Fiscal 2026 Financial Results